Allan Moss (ex MD at Macquarie) bought nearly 10% of the company in the most recent capital raising. Whom am I to disagree!???
The board is extremely accomplished in this field and upside seems enormous if clinical trials are successful. A lot of their compensation seems to be tied to stock options vested @ 0,60c. Seems like an easy bet to me.
Allan Moss (ex MD at Macquarie) bought nearly 10% of the company...
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
0.005(4.17%) |
Mkt cap ! $34.34M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 14.0¢ | 12.5¢ | $106.8K | 808.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 96535 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 12243 | 2 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| ATX (ASX) Chart |